Simplex Trading
BMRN icon

Simplex Trading’s BioMarin Pharmaceuticals BMRN Stock Holding History

Simplex Trading’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.22M Sell
57,000
-30,000
-34% -$1.75M ﹤0.01% 1442
2025
Q4 		$5.17M Buy
87,000
+27,700
+47% +$1.51M ﹤0.01% 1237
2025
Q3 		$3.21M Buy
59,300
+1,000
+2% +$57.2K ﹤0.01% 1866
2025
Q2 		$3.2M Buy
58,300
+13,400
+30% +$789K ﹤0.01% 1709
2025
Q1 		$3.17M Buy
44,900
+20,700
+86% +$1.39M ﹤0.01% 1612
2024
Q4 		$1.59M Sell
24,200
-26,900
-53% -$1.8M ﹤0.01% 2395
2024
Q3 		$3.59M Sell
51,100
-105,700
-67% -$8.84M ﹤0.01% 1764
2024
Q2 		$12.9M Buy
156,800
+118,200
+306% +$9.84M 0.01% 864
2024
Q1 		$3.37M Sell
38,600
-14,200
-27% -$1.27M ﹤0.01% 1929
2023
Q4 		$5.09M Sell
52,800
-5,800
-10% -$513K ﹤0.01% 1530
2023
Q3 		$5.18M Sell
58,600
-36,300
-38% -$3.23M ﹤0.01% 1325
2023
Q2 		$8.22M Buy
94,900
+45,700
+93% +$4.3M 0.01% 1012
2023
Q1 		$4.78M Sell
49,200
-27,600
-36% -$2.86M ﹤0.01% 1328
2022
Q4 		$7.95M Buy
76,800
+15,400
+25% +$1.45M 0.01% 949
2022
Q3 		$5.2M Buy
61,400
+17,500
+40% +$1.56M 0.01% 1176
2022
Q2 		$3.64M Buy
43,900
+12,400
+39% +$987K ﹤0.01% 1351
2022
Q1 		$2.43M Sell
31,500
-15,800
-33% -$1.32M ﹤0.01% 1907
2021
Q4 		$4.18M Buy
47,300
+12,300
+35% +$1.01M ﹤0.01% 1349
2021
Q3 		$2.94M Hold
35,000
– – ﹤0.01% 1693
2021
Q2 		$2.92M Buy
35,000
+34,248
+4,554% +$2.71M ﹤0.01% 1705
2021
Q1 		$5.68M Sell
752
-1,275
-63% -$104K 0.01% 736
2020
Q4 		$17.8M Buy
2,027
+1,019
+101% +$80.8K 0.02% 384
2020
Q3 		$7.67M Buy
1,008
+480
+91% +$48.6K 0.01% 636
2020
Q2 		$6.51M Buy
528
+37
+8% +$3.68K 0.01% 707
2020
Q1 		$4.15M Buy
491
+153
+45% +$13.2K 0.01% 798
2019
Q4 		$2.86M Buy
338
+74
+28% +$5.59K 0.01% 1192
2019
Q3 		$1.78M Buy
264
+88
+50% +$6.78K 0.01% 1421
2019
Q2 		$1.51M Buy
176
+95
+117% +$8.13K ﹤0.01% 1540
2019
Q1 		$719K Sell
81
-73
-47% -$6.77K ﹤0.01% 2284
2018
Q4 		$1.31M Sell
154
-24
-13% -$2.28K ﹤0.01% 1408
2018
Q3 		$1.73M Sell
178
-165
-48% -$16.5K 0.01% 1368
2018
Q2 		$3.23M Buy
343
+280
+444% +$24.5K 0.01% 804
2018
Q1 		$23K Sell
63
-95
-60% -$8.15K ﹤0.01% 3214
2017
Q4 		$61K Buy
158
+16
+11% +$1.39K ﹤0.01% 2245
2017
Q3 		$92K Buy
142
+63
+80% +$5.57K ﹤0.01% 1778
2017
Q2 		$25K Sell
79
-36
-31% -$3.27K ﹤0.01% 3067
2017
Q1 		$34K Sell
115
-51
-31% -$4.54K ﹤0.01% 2724
2016
Q4 		$78K Sell
166
-73
-31% -$6.28K ﹤0.01% 1744
2016
Q3 		$56K Sell
239
-127
-35% -$12K ﹤0.01% 2002
2016
Q2 		$23K Sell
366
-72
-16% -$6.12K ﹤0.01% 2764
2016
Q1 		$141K Buy
438
+207
+90% +$16.8K 0.01% 1090
2015
Q4 		$206K Sell
231
-299
-56% -$31.2K 0.02% 857
2015
Q3 		$175K Buy
530
+200
+61% +$26.7K 0.01% 999
2015
Q2 		$553K Sell
330
-37
-10% -$4.58K 0.05% 365
2015
Q1 		$969K Buy
367
+176
+92% +$18.6K 0.11% 165
2014
Q4 		$398K Buy
+191
New +$15.9K 0.05% 342

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's BMRN Position: Q4 2025 in Review

Simplex Trading sold out of BioMarin Pharmaceuticals (BMRN) in Q4 2025, closing a stake of 23,096 shares — an estimated $1.26M sold.

Simplex Trading first reported a position in BMRN in Q3 2015 and held it in 33 quarters. The position peaked at $3.17M in Q4 2024. 538 funds tracked by Wall St. Rank hold BMRN as of Q4 2025.

  • Simplex Trading reported no remaining BioMarin Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 23,096 BioMarin Pharmaceuticals shares in Q4 2025, an estimated $1.26M.
  • Simplex Trading first reported a position in BioMarin Pharmaceuticals in Q3 2015 and held it in 33 quarters.
  • Simplex Trading's BioMarin Pharmaceuticals position peaked at $3.17M in Q4 2024.
  • 538 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.